Key facts
- This page summarizes Lucile Blaise's Form 4 filing for RESMED INC (RMD).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Nov 2023, 18:47.
Lucile Blaise - 16 Nov 2023 Form 4 Insider Report for RESMED INC (RMD)
- Reporting relationship
- President, Sleep & RC Business
- Issuer ticker
- RMD
- Reported as of
- 16 Nov 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Nov 2023, 18:47:19 UTC
- Prior SEC filing
- 15 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- Lucile Blaise, President, Sleep & Respiratory Care
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lucile Blaise filed Form 4 for RESMED INC (RMD) on 16 Nov 2023.
Change
- Previous filing in this sequence was filed on 15 Nov 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RMD
holding
ResMed Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,305
- Date
- 16 Nov 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Lucile Blaise is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
Ms. Blaise role change is not subject to reporting effective November, 16,2023.